STOCK TITAN
  1. Home
  2. Sec-filings
  3. TDOC
  4. [144] Teladoc Health, Inc. SEC Filing

Teladoc officer plans sale of 9,812 shares

An officer of Teladoc Health filed a Rule 144 notice to potentially sell 9,812 shares of TDOC common stock through a broker.

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Teladoc Health, Inc. (TDOC) is the issuer for a planned sale of common stock reported under Rule 144 by officer Fernando Madeira Rodrigues. The notice covers up to 9,812 shares of common stock, to be sold through Fidelity Brokerage Services LLC.

The filing also lists prior sales of Teladoc common stock by Fernando Madeira Rodrigues during the past three months, including transactions on June 3, 2026 and September 2, 2026, with total reported proceeds in the tens of thousands of dollars.

Positive

  • None.

Negative

  • None.
Proposed shares to be sold under Rule 144 9,812 shares Common stock covered by the Form 144 notice
Shares sold on June 3, 2026 9,572 shares Past 3 months sales table for Teladoc common stock
Proceeds from June 3, 2026 sale $70,832.80 Reported sale of 9,572 shares of common stock
Shares sold on September 2, 2026 5,439 shares Past 3 months sales table for Teladoc common stock
Proceeds from September 2, 2026 sale $34,272.77 Reported sale of 5,439 shares of common stock
Acquisition date of shares to be sold September 1, 2026 Restricted stock vesting date for the 9,812 shares
Notice date September 3, 2026 Date associated with the Form 144 remarks/signature
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Restricted Stock Vesting financial
"Common | 09/01/2026 | Restricted Stock Vesting | Issuer"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
attorney-in-fact regulatory
"as attorney-in-fact for Fernando Madeira Rodrigues"
An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.
compensation financial
"9812 | 09/01/2026 | Compensation"

FAQ

What does the Form 144 filing disclose for Teladoc Health (TDOC)?
It discloses that officer Fernando Madeira Rodrigues filed a Rule 144 notice for a potential sale of up to 9,812 shares of Teladoc Health common stock through Fidelity Brokerage Services LLC, with the shares acquired via restricted stock vesting on September 1, 2026.

How many Teladoc Health (TDOC) shares are proposed to be sold under this Form 144?
The notice covers a proposed sale of up to 9,812 shares of Teladoc Health common stock. These shares are listed as acquired on September 1, 2026 through Restricted Stock Vesting and may be sold as compensation transactions.

Which broker is handling the potential Rule 144 sale for TDOC shares?
The proposed Rule 144 sale of Teladoc Health common stock is to be executed through Fidelity Brokerage Services LLC, located in Smithfield, Rhode Island. The filing lists Fidelity as the broker for the 9,812 shares covered by the notice.

What prior Teladoc Health (TDOC) stock sales are reported in the last three months?
The filing reports two past sales by Fernando Madeira Rodrigues: on June 3, 2026, 9,572 shares of common stock were sold for $70,832.80, and on September 2, 2026, 5,439 shares were sold for $34,272.77.

Who is the person selling Teladoc Health (TDOC) shares under this Form 144?
The person is Fernando Madeira Rodrigues, identified as an officer of Teladoc Health, Inc. The Form 144 is signed by Jennifer Ruchti as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Fernando Madeira Rodrigues.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR